Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

3439 - Role of circulating miRNAs as prognostic biomarkers in resected early-stage non-small cell lung cancer


11 Sep 2017


Poster display session


Cancers in Adolescents and Young Adults (AYA);  Translational Research;  Non-Small Cell Lung Cancer


Paola Ulivi


Annals of Oncology (2017) 28 (suppl_5): v22-v42. 10.1093/annonc/mdx363


P. Ulivi1, E. Petracci2, V. Ludovini3, G. Marisi1, A. Delmonte4, N. De Luigi4, D. Calistri1, L. Crinò4, D. Amadori4, R. Chiari3, S. Baglivo3, F. Grignani5

Author affiliations

  • 1 Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 - Meldola/IT
  • 2 Biostatistics And Clinical Trials Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)- IRCCS, Meldola/IT
  • 3 Medical Oncology, Ospedale S. Maria della Misericordia, 06156 - Perugia/IT
  • 4 Department Of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola/IT
  • 5 Pathology Unit, Perugia Hospital, 06100 - Perugia/IT


Abstract 3439


Non-small cell lung cancer (NSCLC) is the primary cause of cancer-related death, with a 5-year survival rate < 16% mainly because of disseminated disease, even in fully resected early-stage disease. Biomarkers identifying patients at a higher risk of relapse would be useful and circulating microRNAs (miRNAs) are a promising option in this setting.


We analyzed a case series of 182 patients with resected early stage (IA-IIIA) NSCLC (99 adenocarcinoma [ADC] and 83 squamous cell carcinoma [SCC]). Peripheral blood samples were collected from each patient before surgical resection and serum was obtained after centrifugation and stored at -80 °C until miRNA extraction. A panel of 84 circulating miRNAs was analyzed by Real Time PCR. Data were normalized using an external spike-in (cel-miR-39) and the mean of the two most stable endogenous housekeeping genes chosen separately for ADC and SCC samples. miRNA expression was analyzed in relation to disease-free survival (DFS) by the Cox regression model. Results are reported as hazard ratios (HRs) and 95% confidence intervals (CIs).


In ADC patients, stage was significantly associated with DFS (HR stage II-IIIA vs stage I = 4.94, 95% CI [2.71 - 9.02]). Multiple statistical methods were used to evaluate miRNA expression data. In univariate analysis, two miRNAs (miR-222-3p and miR-22-3p) were significantly associated with DFS (p = 0.033 and p = 0.041, respectively). However, this significance was not maintained after adjusting for multiple testing. In SCC patients, disease stage was significantly related to DFS (HR stage II-IIIA vs stage I = 3.31, 95% CI [1.74 - 6.33]). Five miRNAs (let-7a-5p, miR-126-3p, miR-26a-5p, miR-130b-3p, miR-21-5p) were significantly associated with DFS even after adjusting for multiple testing (False Discovery Rate q-value


Pre-surgery circulating levels of let-7a-5p, miR-126-3p, miR-26a-5p, miR-130b-3p and miR-21-5p would appear to be significantly correlated with prognosis in resected early-stage SCC.

Clinical trial identification

Not applicable

Legal entity responsible for the study





All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.